Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia
2012; American Association for Cancer Research; Volume: 18; Issue: 14 Linguagem: Inglês
10.1158/1078-0432.ccr-11-2342
ISSN1557-3265
AutoresJennifer R. Brown, Megan Hanna, Bethany Tesar, Lillian Werner, Nathalie Pochet, John M. Asara, Yaoyu E. Wang, Paola Dal Cin, Stacey M. Fernandes, Christina Thompson, Laura E. MacConaill, Catherine J. Wu, Yves Van de Peer, Mick Correll, Aviv Regev, Donna Neuberg, Arnold S. Freedman,
Tópico(s)Immunodeficiency and Autoimmune Disorders
ResumoThe disease course of chronic lymphocytic leukemia (CLL) varies significantly within cytogenetic groups. We hypothesized that high-resolution genomic analysis of CLL would identify additional recurrent abnormalities associated with short time-to-first therapy (TTFT).
Referência(s)